Clinical Outcomes and Health Care Costs Combining Metformin With Sitagliptin or Sulphonylureas or Thiazolidinediones in Uncontrolled Type 2 Diabetes Patients
ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s63666
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2014
Authors
Publisher
Informa UK Limited